fda warning letters glp-1 november 2025 Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s September 8, 2025: FDA launches

Compounding should continue to serve its intended purpose: meeting the individualized needs of patients when an FDA-approved option is not appropriate or available

If it is for general longevity, skin health, or detoxification support, it is likely a great addition

Reached your goal weight using medication but need help maintaining

Second, no clinical trials have specifically evaluated these interventions for POD prevention, representing a fundamental evidence gap

When it binds to GLP-1 receptors in the brain and digestive system, it slows gastric emptying, reduces appetite signaling, and improves insulin sensitivity

Medical Issues: Certain medications used for depression, high blood pressure, and allergies may cause adverse effects that interfere with sleep